The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice
Abstract
Multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS), is characterized by neuroinflammation and neurodegeneration. Both the innate and adaptive immune systems, with effector cells such as B and T lymphocytes, are critically involved in the pathogenesis of MS. Existing disease-modifying therapies have limited efficacy against progressive MS, and there is a strong need to identify new drug targets. Investigating how peripheral organs influence lymphocyte dynamics in the pathogenesis of MS may provide new insights for identifying novel therapeutic targets. The spleen is the largest secondary lymphoid organ with several immunological roles, including the activation of naïve CD4+ T cells. In this study, we investigated the contribution of the spleen to experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS, in splenectomized (SPX) mice. SPX mice exhibited more severe EAE symptoms and larger demyelinated areas than sham-operated controls. SPX mice showed enhanced T-helper type 1 (Th1) differentiation at the onset of the disease and increased activation of ionized calcium-binding adapter molecule 1 (Iba1)-immunopositive myeloid cells at the peak of the disease. Thus, we inferred that the spleen plays an important role in the pathology of EAE by regulating microglial activation and macrophage infiltration during the disease’s acute phase.
Related
- Mast cell-derived histamine negatively regulates hematopoiesis
- The FOS transcription factor negatively regulates MAFF to control myometrial cell contractility
- A Self-Developed IL-6Rα Nanobody Alleviates Experimental Autoimmune Uveitis by Inhibiting Th1 and Th17 Cells
- Finerenone attenuates experimental autoimmune myocarditis and modulates cardiac macrophage and Th17-cell responses
- Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review
BibTeX
@article{sawada2026spleen,
title = {{The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice}},
author = {Kyoko Sawada and Kazunao Taniyama and Kosei Tamada and Kazuki Nagayasu and Hisashi Shirakawa},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = jul,
doi = {10.1248/bpb.b26-00230},
url = {https://www.jstage.jst.go.jp/article/bpb/49/7/49_b26-00230/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice
AU - Kyoko Sawada
AU - Kazunao Taniyama
AU - Kosei Tamada
AU - Kazuki Nagayasu
AU - Hisashi Shirakawa
PY - 2026
DA - 2026/07/07
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00230
UR - https://www.jstage.jst.go.jp/article/bpb/49/7/49_b26-00230/_article
AB - Multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS), is characterized by neuroinflammation and neurodegeneration. Both the innate and adaptive immune systems, with effector cells such as B and T lymphocytes, are critically involved in the pathogenesis of MS. Existing disease-modifying therapies have limited efficacy against progressive MS, and there is a strong need to identify new drug targets. Investigating how peripheral organs influence lymphocyte dynamics in the pathogenesis of MS may provide new insights for identifying novel therapeutic targets. The spleen is the largest secondary lymphoid organ with several immunological roles, including the activation of naïve CD4+ T cells. In this study, we investigated the contribution of the spleen to experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS, in splenectomized (SPX) mice. SPX mice exhibited more severe EAE symptoms and larger demyelinated areas than sham-operated controls. SPX mice showed enhanced T-helper type 1 (Th1) differentiation at the onset of the disease and increased activation of ionized calcium-binding adapter molecule 1 (Iba1)-immunopositive myeloid cells at the peak of the disease. Thus, we inferred that the spleen plays an important role in the pathology of EAE by regulating microglial activation and macrophage infiltration during the disease’s acute phase.
SN - 1347-5215
SN - 0918-6158
ER -